| Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study RJ Perry, A Tamborska, B Singh, B Craven, R Marigold, P Arthur-Farraj, ... The Lancet 398 (10306), 1147-1156, 2021 | 181 | 2021 |
| Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases RK Boyapati, A Tamborska, DA Dorward, GT Ho F1000Research 6, 2017 | 151 | 2017 |
| Mitochondrial DNA is a pro-inflammatory damage-associated molecular pattern released during active IBD RK Boyapati, DA Dorward, A Tamborska, R Kalla, NT Ventham, ... Inflammatory bowel diseases 24 (10), 2113-2122, 2018 | 103 | 2018 |
| Evaluation of appendicitis risk prediction models in adults with suspected appendicitis Journal of British Surgery 107 (1), 73-86, 2020 | 98 | 2020 |
| Neurological events reported after COVID‐19 vaccines: an analysis of vaccine adverse event reporting system JA Frontera, AA Tamborska, MF Doheim, D Garcia‐Azorin, H Gezegen, ... Annals of Neurology 91 (6), 756-771, 2022 | 97 | 2022 |
| Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional … M Butler, A Tamborska, GK Wood, M Ellul, RH Thomas, I Galea, S Pett, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (11), 1144-1151, 2021 | 48 | 2021 |
| COVID-19 vaccine associated demyelination & its association with MOG antibody M Netravathi, K Dhamija, M Gupta, A Tamborska, A Nalini, VV Holla, ... Multiple sclerosis and related disorders 60, 103739, 2022 | 43 | 2022 |
| Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions KT Thakur, A Tamborska, GK Wood, E McNeill, D Roh, IJ Akpan, EC Miller, ... Journal of the neurological sciences 427, 117532, 2021 | 43 | 2021 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 34 | 2022 |
| Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform JL Walker, A Schultze, J Tazare, A Tamborska, B Singh, K Donegan, ... Vaccine 40 (32), 4479-4487, 2022 | 22 | 2022 |
| CVT After Immunisation Against COVID-19 (CAIAC) collaborators. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: A multicentre cohort study RJ Perry, A Tamborska, B Singh, B Craven, R Marigold, P Arthur-Farraj, ... Lancet 398 (10306), 1147-1156, 2021 | 21 | 2021 |
| Consensus clinical guidance for diagnosis and management of adult COVID-19 encephalopathy patients BD Michael, D Walton, E Westenberg, D García-Azorín, B Singh, ... The Journal of neuropsychiatry and clinical neurosciences 35 (1), 12-27, 2023 | 19 | 2023 |
| Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports D Garcia-Azorin, B Baykan, E Beghi, MF Doheim, ... Cephalalgia 42 (11-12), 1207-1217, 2022 | 14 | 2022 |
| Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study AA Tamborska, B Singh, SE Leonhard, EM Hodel, J Stowe, ... BMJ neurology open 4 (2), 2022 | 13 | 2022 |
| contributors from the Global COVID-19 Neuro Research Coalition. Neurological events reported after COVID-19 vaccines: an analysis of VAERS JA Frontera, AA Tamborska, MF Doheim, D Garcia-Azorin, H Gezegen, ... Ann Neurol 91 (6), 756-771, 2022 | 10 | 2022 |
| Characteristics of randomized trials focusing on stroke due to intracerebral hemorrhage: systematic review A Tamborska, MTC Poon, R Al-Shahi Salman Stroke 49 (3), 594-600, 2018 | 9 | 2018 |
| Non-invasive measurement of fasciculation frequency demonstrates diagnostic accuracy in amyotrophic lateral sclerosis A Tamborska, J Bashford, A Wickham, R Iniesta, U Masood, C Cabassi, ... Brain Communications 2 (2), fcaa141, 2020 | 8 | 2020 |
| Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res. 2017; 6: 169 RK Boyapati, A Tamborska, DA Dorward, GT Ho PubMed Abstract| Publisher Full Text| Free Full Text, 0 | 6 | |
| Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses BD Michael, C Dunai, EJ Needham, K Tharmaratnam, R Williams, ... Nature communications 14 (1), 8487, 2023 | 4 | 2023 |
| Advances in the Understanding of Mitochondrial DNA As a Pathogenic Factor in Inflammatory Diseases, F1000Research, 2017 RK Boyapati, A Tamborska, DA Dorward, GT Ho | 3 | |
